XTalks

DECEMBER 4, 2024

Jupiter Neurosciences, a clinical-stage pharma company specializing in neuroinflammation, made its public market debut with an initial public offering (IPO) on the Nasdaq Capital Market under the symbol “JUNS.” ” The company priced 2,750,000 shares of common stock at $4.00

Bioavailability 111

Bioavailability Genetic Disease Marketing RNA 111

XTalks

JUNE 14, 2024

Ontario, Canada’s largest province by population, is stepping up its commitment to the life sciences sector with an investment of $40 million. The $40 million will come from the Venture Ontario Fund, which is dedicated to helping Ontario life sciences companies and biomanufacturers innovate, grow and compete in global markets.

Life Science 52

Life Science Insulin Research Manufacturing 52

XTalks

DECEMBER 20, 2023

In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

XTalks

JANUARY 20, 2025

From Bristol-Myers Squibbs monumental acquisition of Celgene to Pfizers recent purchase of Seagen, these deals illustrate the strategies and ambitions driving innovation in life sciences. Key drivers of the acquisition included Allergans robust product portfolio, particularly in ophthalmology, neuroscience and aesthetics.

Marketing 104

Marketing Botox Life Science Pharma Companies 104

pharmaphorum

AUGUST 18, 2020

Pharma companies have improved how they engage with healthcare providers as a result of COVID-19, according to a new survey of HCPs. This has resulted in pharma companies being more relevant and providing more value in closing the care gap, the report says.

Pharma Companies 130

Pharma Companies Sales Life Science Marketing 130

Pharmaceutical Technology

MAY 24, 2023

Every major pharma company is now involved in CGT development which has resulted in the approval of 28 therapies by the FDA thereby making CGT no longer a niche category of therapies. Allogeneic therapies begin with healthy donor samples to develop the eventual therapeutic product which can be administered to multiple patients.

Clinical Trials 246

Clinical Trials Clinical Trials Gene Therapy Clinical Supply Chain 246

XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

Pharmaceutical Technology

MAY 26, 2023

Pharma company merger and acquisition (M&A) activity in the first half of 2023 has remained relatively low, consistent with the second half of last year, but investors predict deals will increase later in 2023. Experts at PWC, Goldman Sachs, and Morgan Stanley agree that pharma-related M&A is expected to pick up in 2023.

Life Science 130

Life Science Manufacturing Contract Manufacturing Gene Therapy 130

pharmaphorum

MARCH 2, 2021

UK chancellor Rishi Sunak has been urged to recognise the leading role that pharma companies are playing in the economy in this week’s budget. According to a report last month from the BioIndustry Association, covering life sciences and biotech, there was a record $2.8

Life Science 105

Life Science Vaccination Vaccine Pharma Companies 105

The Pharma Data

DECEMBER 9, 2020

This partnership provides SOLABS’ Life Sciences clients with exciting capabilities in the areas of reporting and analytics. MONTREAL, QC, December 09, 2020 /24-7PressRelease/ — SOLABS enters into a partnership with NexGen Analytics. “We are a product of teamwork, with our clients, our colleagues and our partners.

Life Science 52

Life Science Packaging Packaging Pharma Companies 52

Pharmaceutical Technology

JULY 26, 2022

Following the merger, NewAmsterdam Pharma CEO Dr Michael Davidson will lead the newly formed holding company, which is expected to be named NewAmsterdam Pharma Company. In January last year, NewAmsterdam Pharma raised $196m in a Series A funding round to support the full Phase III development of obicetrapib.

Life Science 147

Life Science Trials Pharma Companies Production 147

pharmaphorum

JANUARY 19, 2021

A new survey highlights the importance of customer reference data to digital transformation and analyses ways pharma companies can improve the quality of their datasets. More pharma companies are moving in this direction, and 78% of respondents said they are undertaking, or planning, a customer data enhancement initiative.

Sales 104

Sales Pharma Companies Life Science Production 104

pharmaphorum

MAY 13, 2021

Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. Rather than simply surviving, the life sciences industry needs to respond proactively. About Veeva Systems.

Life Science 105

Life Science Sales Pharma Companies Production 105

pharmaphorum

JUNE 10, 2022

If you work in pharma, the chances are you’re no stranger to the United States Food and Drug Administration, or FDA, which regulates pharmaceuticals. A device means a product that’s used in the diagnosis of disease and intended to affect the structure and function of the body of humans,” Faget said.

Regulation 133

Regulation Production Life Science Drugs 133

XTalks

MAY 29, 2024

The top ten pharma companies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 The top big pharma players have remained relatively consistent in their market positions over the past several years. Here is a look at the top ten pharma companies in 2024 based on 2023 revenue.

Pharma Companies 52

Pharma Companies Sales FDA Approval Vaccination 52

pharmaphorum

MARCH 22, 2021

For the past year, life science companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. India and China have seen the emergence of strong, local pharma companies. With India and China having populations of 1.3

Manufacturing 122

Manufacturing Marketing Vaccination Vaccine 122

pharmaphorum

NOVEMBER 3, 2021

Pharma companies are producing and distributing more digital content than ever due to the pandemic, meaning the content presented needs to stand out in the crowded digital space to garner attention. Content metrics is the collection of data related to an industry or a company’s content. Read the full Veeva Systems report.

Pharma Companies 98

Pharma Companies Life Science Marketing Branding 98

pharmaphorum

OCTOBER 19, 2022

Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave of innovation hitting the content world in life sciences, and rightly so because HCPs’ needs and expectations have changed. “There isn’t a one-size-fits-all for how the life sciences industry creates content.

Life Science 97

Life Science Production Compliance Pharma Companies 97

pharmaphorum

DECEMBER 7, 2021

Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). For the most part, life science companies have a relatively good knowledge of what their audiences want and need from them.

Life Science 105

Life Science Pharma Companies Branding Marketing 105

pharmaphorum

SEPTEMBER 15, 2020

For pharma companies, COVID-19 has proved that they can be agile and responsive to rapidly evolving market conditions, as evidenced by the way they have adjusted to a new global paradigm while successfully continuing operations. Preparing for an agile pharma future. Jeremy Richter, Tag. Build on the rapid responses to COVID-19.

Branding 130

Branding Marketing Pharma Companies Life Science 130

Pharmaceutical Technology

FEBRUARY 13, 2023

To tackle this, companies have developed different ways to focus on the gene. Rather than replacing mutated genes with functional copies, STK-001 promotes protein production in the healthy copy of the SCN1a gene. SK Life Science is a subsidiary of SK, a South Korean holding company.

Research 264

Research Gene Gene Therapy Genomics 264

Pharmaceutical Technology

OCTOBER 28, 2022

According to Alex Edwards, solutions architect at leading pharmaceutical translations provider RWS: “Pharma companies have three years until EU-CTR is mandatory, but it's in everyone's interest to start sooner rather than later. A key part of this includes the careful selection of personnel for the lay summary production.

Clinical Trials 130

Clinical Trials Clinical Trials Life Science Trials 130

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Life Science 98

Life Science Pharma Companies Sales Marketing 98

pharmaphorum

MAY 18, 2021

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. He takes us through the challenges of a successful launch and explains what pre-commercial companies need to focus on to hit their goals. Building strong data foundations. ” says Hale.

Production 52

Production Sales Life Science Marketing 52

pharmaphorum

MARCH 9, 2021

Meanwhile, field teams’ promotional content is still reflective of the pre-COVID paradigm, and Noel says companies need to rethink what content messages will be beneficial for HCPs. Reps should not just be pushing product messages – they should be asking doctors what they need right now and how they can help.”.

Sales 131

Sales Doctors Doctor Marketing 131

pharmaphorum

FEBRUARY 17, 2021

Armed with these insights, life sciences companies can develop patient-centric solutions that will lead to more successful products. Importantly, you can ensure product and service messages are relevant to patients and add value, driving competitive advantage in increasingly crowded landscapes.

Life Science 98

Life Science Genetics Branding Trials 98

XTalks

MARCH 20, 2025

The biotech company reported robust financial results for the fourth quarter and full year of 2024. The company achieved a 12% increase in full-year product revenue compared to 2023, totaling $11.02 This investment aims to meet the growing global demand for its products and ensure a reliable supply chain.

Sales 59

Sales Production Drugs Development 59

pharmaphorum

MARCH 26, 2021

The UK Government and EU Commission trumpeted their Brexit trade deal, struck at the end of December, as ‘comprehensive’, the ‘biggest yet’ But a closer inspection of the EU-UK Trade and Cooperation Agreement (TCA) renders these statements largely illusory for the pharma sector. The Medicinal Products Annex.

Production 119

Production Medicine Marketing Regulation 119

XTalks

JULY 16, 2021

The company said that while benzene is not an ingredient in any of its sunscreen products, it was detected during routine internal testing in some samples of its aerosol sunscreen finished products. Therefore, levels should be monitored at different stages of production to avoid harmful benzene contamination.

Contamination 105

Contamination Production Drugs Branding 105

pharmaphorum

MARCH 2, 2022

There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments. The latter compound has already been approved for treatment-resistance depression as the product Spravato (esketamine), after being developed by Janssen.

Life Science 105

Life Science Clinical Trials Clinical Trials Trials 105

pharmaphorum

JUNE 9, 2021

At Fishawack Health, we are always seeking opportunities to enhance our capabilities and help our life science clients navigate the new, dynamically changing healthcare environment. Meet closerlook. Meet closerlook.

Marketing 73

Marketing Life Science Branding Development 73

pharmaphorum

DECEMBER 16, 2020

Experts from Healthware Group explore how companies can rebuild their approach to digital from the ground up for the benefit of patients. Digital is not just a nice-to-have for pharma companies – it’s a necessity for ensuring that patients have the best possible outcomes in modern healthcare systems.

Life Science 59

Life Science Pharma Companies Sales Medicine 59

XTalks

MAY 6, 2022

They discussed current challenges and solutions that life science companies and clinical development organizations have with the management of clinical data. To produce ethical results in a timely manner, life science companies should ensure that they have a robust and reliable clinical data pipeline in place.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

XTalks

JANUARY 11, 2021

Companies outsource to gain access to specialized expertise and technology, scale pharmacovigilance (PV) activities, and reduce costs. However, the efficiency and effectiveness of externalized safety activities are below expectations for many biotech and pharma companies.

Pharma Companies 90

Pharma Companies Compliance Clinical Outsourcing Regulation 90

pharmaphorum

NOVEMBER 15, 2022

On 14th November, investors and life science & healthcare executives descended on London’s famed Old Billingsgate building to attend LSX’s Inv€$tival Showcase, part of Europe’s biggest dedicated healthcare investment week. Investing in the future of the European life sciences. For Müllenbeck, this is an opportunity.

Life Science 96

Life Science Pharma Companies Marketing Production 96

pharmaphorum

MAY 24, 2022

Pharma companies generate lots of data and bring in other data to support their actions but not all of it gets used which is where we come in,” says Thomas Kurian, head of new markets at Treasure Data, which powers some of the largest companies in pharmaceuticals. Swift Integration. We offer best-in-class security.

Marketing 111

Marketing Sales Life Science Pharma Companies 111

pharmaphorum

NOVEMBER 23, 2022

A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My We have built a product that is universal, that can really bring any pharma party, any payers in any market to really work together. Innovative offerings around market access.

Life Science 98

Life Science Marketing Medicine Production 98